arsenic trioxide has been researched along with Experimental Hepatoma in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, GQ; Fu, X; Liang, QR; Luo, RG; Ouyang, L; Qiu, W; Tang, Q | 1 |
| Carroll, SL; Feng, G; Jiang, T; Jiang, X; Kong, D; Liu, B; Liu, J; Lou, C; Zhao, B | 1 |
| He, LJ; Jia, YL; Nan, X; Pei, XT; Wang, DX; Wang, HY; Xi, JF; Xu, YC; Yue, W; Zeng, Q; Zhang, B; Zhou, JN | 1 |
| Gong, J; Jiang, X; Li, H; Shao, H | 1 |
| Ho, JC; Kwong, YL; Lam, SK; Li, YY; Mak, JC; Zheng, CY | 1 |
| Akrami, SM; Habibi, L; Karimi, A; Madjd, Z | 1 |
| Fu, HQ; Huang, MW; Wang, K; Wang, KY; Wu, LQ; Yin, XB; Yu, X; Zhou, F | 1 |
| Guo, CG; Peng, ZY; Sun, JH; Xu, SL; Zou, Y | 1 |
| Cheng, L; Cheng, P; Huang, A; Liao, D; Ma, J; Tong, A; Wei, Y; Yue, D | 1 |
| Peng, J; Yang, M; Yang, Z | 1 |
| Cao, Z; Cui, L; Hu, Z; Li, T; Zhang, S; Zhang, W | 1 |
| An, Y; Li, Y; Liu, J; Wang, L; Wang, Z; Zhang, D; Zhang, J | 1 |
| Chen, G; Chen, JX; Hua, ZC; Tang, B; Wang, K; Yang, BY | 1 |
| Calderon, PB; Dauguet, N; Diepart, C; Feron, O; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Leveque, P; Magat, J; Stockis, J; Verrax, J | 1 |
| Hong, L; Qi, QH; Wang, SS; Wang, XL; Zhang, T | 1 |
| Bi, L; Chen, SX; Liu, SM; Xu, HY; Yang, YL | 1 |
| Chen, W; Guo, HX; Jiang, HC; Liu, LX; Liu, ZH; Wang, XQ; Wu, M; Zhang, TD; Zhu, AL | 1 |
| Huang, JF; Ni, RZ; Tan, B; Wei, Q; Zhang, H | 2 |
| Dong, X; Jiang, H; Krissansen, GW; Liu, B; Pan, S; Qiao, H; Sun, X | 1 |
| Chen, H; Pan, Q; Qin, S | 1 |
| Chen, BA; Chen, HY; Qin, SK; Wang, W | 1 |
22 other study(ies) available for arsenic trioxide and Experimental Hepatoma
| Article | Year |
|---|---|
Sustained release of arsenic trioxide benefits interventional therapy on rabbit VX2 liver tumor.
Topics: Animals; Arsenic Trioxide; Chemoembolization, Therapeutic; Delayed-Action Preparations; Ethiodized Oil; Liver Neoplasms, Experimental; Prodrugs; Rabbits | 2020 |
Chemoembolizing hepatocellular carcinoma with microsphere cored with arsenic trioxide microcrystal.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Cell Line, Tumor; Chemoembolization, Therapeutic; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice, Nude; Microspheres; Polylactic Acid-Polyglycolic Acid Copolymer; Reactive Oxygen Species; Solvents; Xenograft Model Antitumor Assays | 2020 |
Arsenic trioxide inhibits liver cancer stem cells and metastasis by targeting SRF/MCM7 complex.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Carcinoma, Hepatocellular; Cell Line, Tumor; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Gene Ontology; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Minichromosome Maintenance Complex Component 7; Neoplastic Stem Cells; Prognosis; Serum Response Factor; Transplantation, Heterologous | 2019 |
Arsenic trioxide treatment of rabbit liver VX-2 carcinoma via hepatic arterial cannulation-induced apoptosis and decreased levels of survivin in the tumor tissue.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Catheterization; Chemoembolization, Therapeutic; Emulsions; Ethiodized Oil; Gene Expression Regulation; Hepatic Artery; In Situ Nick-End Labeling; Infusions, Intra-Arterial; Inhibitor of Apoptosis Proteins; Liver Neoplasms, Experimental; Male; Oxides; Rabbits; Reverse Transcriptase Polymerase Chain Reaction | 2013 |
Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Liver Neoplasms, Experimental; Lung Neoplasms; Mice; Mice, Nude; Oxides; Thymidylate Synthase; Xenograft Model Antitumor Assays | 2014 |
Exposure of hepatocellular carcinoma cells to low-level As₂O₃ causes an extra toxicity pathway via L1 retrotransposition induction.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Coloring Agents; Deoxyribonuclease I; DNA; Flow Cytometry; Green Fluorescent Proteins; Humans; Indicators and Reagents; Liver Neoplasms; Liver Neoplasms, Experimental; Microscopy, Fluorescence; Oxides; Plasmids; Real-Time Polymerase Chain Reaction; Retroelements; Tetrazolium Salts; Thiazoles; Transfection | 2014 |
Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Delivery Systems; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Microvessels; Nanoparticles; Neovascularization, Pathologic; Oxides; Single-Chain Antibodies; Vascular Endothelial Growth Factor Receptor-2 | 2014 |
[Influence of As2O3-lipiodol emulsion via transarterial embolization on a VX2 liver tumor model in rabbits].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Embolization, Therapeutic; Emulsions; Ethiodized Oil; Liver Neoplasms, Experimental; Oxides; Rabbits; Tomography, Spiral Computed | 2015 |
SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Drug Resistance, Neoplasm; Female; Inhibitor of Apoptosis Proteins; Liposomes; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Mutation, Missense; Neoplasm Transplantation; Oxides; Reactive Oxygen Species; Repressor Proteins; Survivin | 2016 |
Evaluation of arsenic trioxide-loaded albumin nanoparticles as carriers: preparation and antitumor efficacy.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Evaluation; Liver Neoplasms, Experimental; Male; Mice; Nanoparticles; Oxides; Particle Size; Serum Albumin, Bovine | 2008 |
Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Proliferation; Combined Modality Therapy; Drug Synergism; Flow Cytometry; Genetic Therapy; In Vitro Techniques; Liver Neoplasms, Experimental; Mice; Mice, Nude; Nuclear Proteins; Oxides; Promyelocytic Leukemia Protein; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2010 |
A study on the thermochemotherapy effect of nanosized As2O3/MZF thermosensitive magnetoliposomes on experimental hepatoma in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Calorimetry, Differential Scanning; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Humans; Hyperthermia, Induced; Liposomes; Liver; Liver Neoplasms, Experimental; Magnetics; Nanoparticles; Oxides; Rabbits | 2011 |
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Diterpenes, Kaurane; Drug Synergism; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; NF-kappa B; Oxides; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; X-Linked Inhibitor of Apoptosis Protein | 2012 |
Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Lewis Lung; Combined Modality Therapy; Disease Models, Animal; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Oxides; Oxygen Consumption; Radiation-Sensitizing Agents | 2012 |
Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Division; Cisplatin; Female; Immunohistochemistry; Kidney; Liver Neoplasms, Experimental; Male; Oxides; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar | 2003 |
Effect of arsenic trioxide on human hepatocarcinoma in nude mice.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blood Platelets; Carcinoma, Hepatocellular; Hemoglobins; Humans; Kidney; Leukocytes; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Oxides | 2004 |
[The effect and mechanism of arsenic trioxide on hepatocellular carcinoma].
Topics: Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Chemotherapy, Cancer, Regional Perfusion; Female; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Middle Aged; Oxides | 2005 |
[Anti-hepatoma effect of arsenic trioxide on rat liver cancers induced by 2-acetamidofluorene].
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Fluoresceins; Liver Neoplasms, Experimental; Male; Oxides; Rats | 2005 |
Anti-hepatoma effect of arsenic trioxide on experimental liver cancer induced by 2-acetamidofluorene in rats.
Topics: 2-Acetylaminofluorene; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinogens; Cell Cycle; Liver Neoplasms, Experimental; Oxides; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2005 |
Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice.
Topics: Animals; Antineoplastic Agents; Aorta; Apoptosis; Arsenic Trioxide; Arsenicals; Cattle; Cell Proliferation; Endothelial Cells; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Oxides; Vascular Endothelial Growth Factor A | 2006 |
[Antitumor effect of arsenic trioxide on mice experimental liver cancer].
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Female; Flow Cytometry; Liver Neoplasms, Experimental; Male; Mice; Oxides; Proto-Oncogene Proteins c-bcl-2 | 2000 |
Experimental study on antitumor effect of arsenic trioxide in combination with cisplatin or doxorubicin on hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cisplatin; Doxorubicin; Female; Humans; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Oxides; Tumor Cells, Cultured | 2001 |